GlassScriptPhysician profile
Jason S Harrod
NPI 1245256270
$858.17
in general payments reported to CMS, 2019-2025
11 companies · $35.25 in 2025
The $35.25 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.24 · 2020: $29.95 · 2021: $23.34 · 2022: $646 · 2023: $33.11 · 2024: $42.80 · 2025: $35.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $323.53 | 2019-2024 | Gamma, Mako |
| Smith+Nephew, INC. | $272.72 | 2022 | |
| Depuy Synthes Sales INC. | $71.79 | 2022-2025 | Healix Knotless Peek, Gryphon Orthocord, Motoband |
| Horizon Therapeutics Plc | $64.87 | 2019-2022 | |
| Breg, INC | $33.13 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.49 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $21.06 | 2019 | |
| Heron Therapeutics, INC. | $18.76 | 2022 | |
| Pacira Therapeutics, INC. | $17.80 | 2020 | |
| Urgo Medical North America, LLC | $13.02 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$39,976.96 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Harrod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.